Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZMYND8 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
mRNA | TCERG1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
mRNA | EMB | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
mRNA | SDCBP | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
mRNA | ZNF395 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
mRNA | UNC93B1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
mRNA | ATP6AP2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
mRNA | FAM159A | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
mRNA | TOMM20 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
mRNA | NAMPT | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |